level-one heading

Kolabtreeを選ぶ理由
開始はすばやく簡単です。初期費用はかかりません。
サービス依頼と専門家への見積依頼は無料です。
Kolabtree の作業範囲に同意する前に、専門家と要件を詳しく相談できます。
専門家と直接連携し、必要な成果を正しく得られます。
専門家を採用したらプロジェクトに資金を入れ、作業完了後に成果物を承認できます。
この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
プロジェクトを作成
★★★★★
☆☆☆☆☆
Dr. Bushra K.に依頼
Pakistan

Scientific writing with 10+ years of experience in clinical research. Haematology and statistics expert.

プロフィール概要
専門分野
サービス
Writing Medical Writing, General Proofreading & Editing
Data & AI Statistical Analysis
職務経験

Senior Lecturer

Jinnah Medical & Dental College

8月 2025 - 現在

Senior Lecturer

Jinnah Medical & Dental College

8月 2025 - 現在

Senior Research Associate

The Indus Hospital Korangi Campus

2019 - 2023

Clinical Research Associate

National Institute of Blood Diseases and Bone Marrow Transplantation

2011 - 2019

学歴

MPhil/PhD (Haematology)

National Institute of Blood Diseases and Bone Marrow Transplantation

- 現在

PhD

Liaquat University of Medical & Health Sciences Jamshoro - Pakistan

1月 2013 - 11月 2024

M.B;B.S

Dow University of Health Sciences

2004 - 2009

M.B;B.S

Dow University of Health Sciences

2004 - 2009

認定資格
  • none

    None

    1月 2025 - 1月 2025

出版物
JOURNAL ARTICLE
Bushra Kaleem, Sadia Parveen, Muhammad Liaquat Raza, Saqib Hussain Ansari, Uzma Zaidi, Tahir Shamsi (2025). Evaluation of hepatotoxicity due to conditioning regimens in beta thalassemia major and aplastic anemia patients undergoing bone marrow transplantation . Journal of Oncology Pharmacy Practice.
Bushra Kaleem, Sadaf Shahab, Tahir Sultan Shamsi (2024). Impacto de la mutación T315I en el pronóstico de la leucemia mieloide crónica . Advances in Laboratory Medicine / Avances en Medicina de Laboratorio.
Bushra Kaleem, Sadaf Shahab, Tahir Sultan Shamsi (2024). T315I – a gatekeeper point mutation and its impact on the prognosis of chronic myeloid leukemia . Advances in Laboratory Medicine / Avances en Medicina de Laboratorio.
Bushra Kaleem, Sadaf Shahab, Uzma Zaidi, Tahir Sultan Shamsi(2022). P‐Loop mutations—Negative prognosticators in tyrosine kinase inhibitors resistant chronic myeloid leukemia patients . International Journal of Laboratory Hematology. Wiley
Kanani, F., Jamal, S., Khowaja, S., Kaleem, B., Kanani, F., Anis, S., Jamal, S., Iftikhar, S., Khowaja, S., Khursheed, N., et al.(2022). Sensitivity and Specificity of Anti-SARS-CoV-2 Detection Kits-Comparison and Agreement between Fifteen Different Assays . Japanese Journal of Infectious Diseases. 75. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 16-23.
Ansari, S.H., Hussain, Z., Zohaib, M., Parveen, S., Kaleem, B., Qamar, H., Adil, O., Khan, M.T., Shamsi, T.S.(2022). A Pragmatic Scoring Tool to Predict Hydroxyurea Response among β-Thalassemia Major Patients in Pakistan . Journal of Pediatric Hematology/Oncology. 44. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString E77-E83.
Kanani, F., Anis, S., Kaleem, B., Jamal, S., Kanani, F., Anis, S., Kaleem, B., Jamal, S.(2022). Association of Seroconversion Status with Outcome in Admitted Covid-19 Patients . Journal of the College of Physicians and Surgeons Pakistan. 32. (7). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 874-879.
Yaqoob, N., Mansoor, S., Zia, N., Aftab, K., Kaleem, B., Jamal, S., Yaqoob, N., Mansoor, S., Zia, N., Aftab, K., et al.(2022). Chemotherapy induced histopathological changes in retinoblastoma, assessment of high risk predictive factors & its correlation with comorbid conditions . Pakistan Journal of Medical Sciences. 38. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 362-368.
Yaqoob, N., Zia, N., Hamid, A., Kaleem, B., Jamal, S., Amin, S., Qaddoumi, I., Jamal, S., Yaqoob, N., Zia, N., et al.(2022). Correlation of clinical and radiological predictors of retinoblastoma with high-risk histopathological features . Pediatric Blood and Cancer. 69. (5).
Jamal, S., Mansoor, N., Kaleem, B., Lateef, F., Yaqoob, N., Jamal, S., Mansoor, N., Kaleem, B., Lateef, F., Yaqoob, N.(2022). FREQUENCY, DISTRIBUTION OF SUBTYPES AND IMMUNOHISTOCHEMICAL PROFILE OF NON-HODGKIN LYMPHOMA IN PAEDIATRIC AND ADOLESCENT PATIENTS . Journal of Ayub Medical College. 34. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 351-356.
Yaqoob, N., Mansoor, S., Aftab, K., Kaleem, B., Hamid, A., Jamal, S., Yaqoob, N., Mansoor, S., Aftab, K., Kaleem, B., et al.(2022). High risk histopathological factors in retinoblastoma in upfront enucleated eyes: An experience from a tertiary care centre of Pakistan . Pakistan Journal of Medical Sciences. 38. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 369-374.
Kaleem, B., Shahab, S., Zaidi, U., Shamsi, T.S., Kaleem, B., Shahab, S., Zaidi, U., Shamsi, T.S.(2022). P-Loop mutations—Negative prognosticators in tyrosine kinase inhibitors resistant chronic myeloid leukemia patients . International Journal of Laboratory Hematology. 44. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 538-546.
Ansari, S.H., Hussain, Z., Zohaib, M., Parveen, S., Kaleem, B., Qamar, H., Adil, O., Khan, M.T., Shamsi, T.S.(2022). A Pragmatic Scoring Tool to Predict Hydroxyurea Response among β-Thalassemia Major Patients in Pakistan . Journal of Pediatric Hematology/Oncology. 44. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString E77-E83.
(2021). Chemotherapy induced histopathological changes in retinoblastoma, assessment of high risk predictive factors & its correlation with comorbid conditions. Pakistan Journal of Medical Sciences.
(2021). High risk histopathological factors in retinoblastoma in upfront enucleated eyes: An experience from a tertiary care centre of Pakistan. Pakistan Journal of Medical Sciences.
(2021). Frequency, distribution of subtypes and immunohistochemical profile of Non-Hodgkin Lymphoma in pediatric and adolescent patients. Journal of Ayub Medical College.
Kanani, F.Z., Haider Kazmi, A., Kaleem, B., Kanani, F.Z., Haider Kazmi, A., Kaleem, B.(2021). Sigma metrics of Alinity ci system - A study on thirty-nine clinical chemistry and immunoassay parameters . Advances in Laboratory Medicine. 2. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 267-275.
Kanani, F.Z., Kazmi, A.H., Kaleem, B., Kanani, F.Z., Kazmi, A.H., Kaleem, B.(2021). Sigma metrics of Alinity ci system: A study on 39 clinical chemistry and immunoassay parameters,La metrica Sigma del sistema Alinity ci: Estudio sobre 39 magnitudes quimicas y de inmunoensayo . Advances in Laboratory Medicine. 2. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 277-285.
Bushra Kaleem, Uzma Zaidi, Gul Sufaida, Munazza Rashid, Sidra Maqsood, Samina Naz Mukry, Rifat Zubair Ahmed Khan, Saima Munzir, Munira Borhany, Tahir Sultan Shamsi(2020). A distinct molecular mutational profile and its clinical impact in essential thrombocythemia and primary myelofibrosis patients . BMC Cancer. 20. (1). Springer Science and Business Media {LLC}
Zaidi, U., Sufaida, G., Rashid, M., Kaleem, B., Maqsood, S., Mukry, S.N., Khan, R.Z.A., Munzir, S., Borhany, M., Shamsi, T.S.(2020). A distinct molecular mutational profile and its clinical impact in essential thrombocythemia and primary myelofibrosis patients . BMC Cancer. 20. (1).
Zaidi, U., Sufaida, G., Rashid, M., Kaleem, B., Maqsood, S., Mukry, S.N., Khan, R.Z.A., Munzir, S., Borhany, M., Shamsi, T.S.(2020). A distinct molecular mutational profile and its clinical impact in essential thrombocythemia and primary myelofibrosis patients . BMC Cancer. 20. (1).
Ansari, S., Rashid, N., Hanifa, A., Siddiqui, S., Kaleem, B., Ansari, S., Rashid, N., Naz, A., Hanifa, A., Perveen, K., et al.(2019). Laboratory diagnosis for thalassemia intermedia: Are we there yet? . Journal of Clinical Laboratory Analysis. 33. (1).
Jamal, A., Jamal, A., Fatima, N., Fatima, N., Shaikh, S., Shaikh, S., Kaleem, B., Kaleem, B., Rizvi, Q.A., Rizvi, Q.A., et al.(2019). Pattern of Antimicrobial Sensitivity in Microbiologically Documented Infections in Neutropenic Patients with Haematological Malignancies: A single Center Study . Indian Journal of Microbiology. 59. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 188-192.
Zaidi, U., Kaleem, B., Borhany, M., Maqsood, S., Fatima, N., Sufaida, G., Ansari, S.H., Farzana, T., Shamsi, T.S., Zaidi, U., et al.(2019). Early and sustained deep molecular response achieved with nilotinib in high Sokal risk chronic myeloid leukemia patients . Cancer Management and Research. 11. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1493-1502.
Ansari, S.H., Parveen, S., Siddiqui, S., Perveen, K., Ahmed, G., Kaleem, B., Ansari, S.H., Parveen, S., Ahmed, S., Zohaib, M., et al.(2018). Managing thalassemia in the developing world: An evidence-based approach for prevention, transfusion independency, and curative treatment with hematopoietic stem cell transplantation . Blood Advances. 2. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 42-45.
Kaleem, B., Kaleem, B., Shahab, S., Ahmed, N., Shamsi, T.S., Shahab, S., Ahmed, N., Shamsi, T.S.(2015). Chronic myeloid leukemia - Prognostic value of mutations . Asian Pacific Journal of Cancer Prevention. 16. (17). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 7415-7423.